These Italian authors conducted
- Some women seek sildenafil for increasing genital blood flow and sensation.
- The placebo effect can influence perceived benefits in women using sildenafil.
- Women with cardiovascular risk should avoid sildenafil unless approved by a doctor.
- Topical or alternative therapies might be considered alongside or instead of sildenafil.
- Scientific consensus on sildenafil’s safety for women remains under development.
- Proper dosing and medical oversight are key to minimizing risks.
a randomized, double-blind, crossover
- Sildenafil is often known by the brand name Viagra, primarily for men.
- Researchers are exploring other PDE5 inhibitors for women’s sexual health.
- Efficacy of sildenafil in women might depend on underlying health conditions.
- Women with cardiovascular issues should be particularly cautious with sildenafil.
- Some women report increased sexual satisfaction after using sildenafil.
- Medical advice is crucial before women consider sildenafil as a treatment.
study to explore the use of sildenafil in
What should I do in case of overdose?
These effects may be more intense if you take birth control pills or drink alcohol. Side effects of Vyleesi include a temporary increase in blood pressure and a decrease in heart rate. It can also cause nausea and isolated spots of skin lightening (focal hyperpigmentation). Viagra is FDA approved to treat erectile dysfunction. It doesn’t have approval for treating female sexual dysfunction, and studies thus far have sildenafil citrate chewable tablets had mixed results.
Exploratory Phase 2b RESPOND Study, Completed in 2023
There’s no “female Viagra,” but there are a couple of drugs with approval to treat sexual dysfunction associated with specific conditions. There are many reasons for low sex drive. Before taking Viagra or any other medication, talk with your doctor about the potential benefits, risks, and side effects of these medications for you. While some side effects such as nausea, dizziness, and headaches associated with selective serotonin reuptake inhibitor (SSRI) antidepressants tend to decrease or resolve over time, other side effects such as sexual dysfunction rarely remit spontaneously. Treatment of sexual side effects in women is especially important when about 30-70% of patients taking antidepressants may experience sexual side effects, combined with the fact that women are prescribed antidepressants at rates of 2 to 1 when compared to men.
Altitude sickness
Sexual side effects in women may entail decreased sexual desire, difficulty with orgasm, genital sensitivity, reduced sexual activity, pain with sexual intercourse, decreased vaginal lubrication, and dissatisfaction or loss of pleasure from sexual activity. Sildenafil, marketed under the name Viagra, is a selective phosphodiesterase type 5 inhibitor approved for the treatment of erectile dysfunction in men, and has received study for men with depression and erectile dysfunction associated with SSRI treatment. In women, initial trials using selective phosphodiesterase inhibitors looking at both premenopausal and postmenopausal women did not show significant improvements for sexual arousal disorder; however, later randomized controlled trials supported their use for the improved frequency of sexual intercourse, arousal, orgasm, and satisfaction. conducted over 7 outpatient medical centers, 98 premenopausal women with remitted depression on SSRI antidepressants, ages 18-50 years old, were enrolled into an 8 week prospective, parallel- group, randomized, double blind, placebo controlled clinical trial. This study used the Clinical Global Impression sexual function scale as a primary measure, and also utilized the Female Sexual Function Questionnaire, the Arizona Sexual Experience Scale-female version, and the University of New Mexico Sexual Function Inventory- female version, a sexual activity event log, and the Hamilton Depression Rating Scale. 51 women (aged 22-38)
| Country | Legal Status | Prescription Required | Notes |
|---|---|---|---|
| USA | Approved for certain uses | Yes | Off-label for women often not approved |
| UK | Prescription-only | Yes | Approved for male ED; off-label use in women |
| Canada | Restricted use | Yes | Prescription required; variable by province |
| Australia | Prescription-only | Yes | Limited clinical guidelines for women |
with documented ovarian function
| Brand Name | Formulation | Dosage Options | Notes |
|---|---|---|---|
| Viagra Women | Oral tablet | 25 mg, 50 mg | Off-label use, not approved by FDA |
| Female Arousal Gel | Topical gel | N/A | Claimed to enhance blood flow |
| Sildenafil Citrate | Generic oral tablet | 25-100 mg | Widely used off-label in women |
| Custom Compounded | Customized formulations | Variable | Prescribed by special clinics |
who reported adequate sexual
- The legality of women using sildenafil varies by country and local regulations.
- Lifestyle modifications can complement medication for better sexual health outcomes.
- Women with diabetes may have different responses to sildenafil therapy.
- The stigma surrounding female sexual dysfunction can hinder treatment seeking.
- Advances in research are aimed at developing female-specific ED medications.
- Open discussions with physicians are essential for safe and effective treatments.
desire but decreased arousal.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 100mg | 120 + 6 Pills | 149.50€ 142.38€ | |
| Viagra Generic | 25mg | 60 + 4 Pills | 71.99€ 68.56€ | |
| Viagra Generic | 150mg | 360 + 10 Pills | 423.48€ 403.31€ | |
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Viagra Generic | 50mg | 30 + 4 Pills | 54.26€ 51.68€ | |
| Kamagra Soft Tabs | 100mg | 32 Pills | 120.11€ 114.39€ | |
| Viagra Generic | 25mg | 180 + 6 Pills | 154.93€ 147.55€ | |
| Kamagra | 100mg | 12 Pills | 55.64€ 52.99€ | |
| Viagra Generic | 50mg | 10 Pills | 26.87€ 25.59€ | |
| Kamagra Oral Jelly | 100mg | 10 Sachets | 54.55€ 51.95€ | |
| Kamagra Soft Tabs | 100mg | 20 Pills | 79.79€ 75.99€ | |
| Viagra Generic | 50mg | 270 + 8 Pills | 198.48€ 189.03€ | |
| Viagra Generic | 100mg | 90 + 6 Pills | 129.02€ 122.88€ | |
| Kamagra | 100mg | 180 + 6 Pills | 436.79€ 415.99€ | |
| Kamagra | 100mg | 84 + 6 Pills | 264.44€ 251.85€ |
Subjects were recruited from a sexual
| Parameter | Description | Typical Values | Notes |
|---|---|---|---|
| Absorption Rate | Time to reach peak plasma levels | 30-120 minutes | Varies with food intake |
| Half-Life | Duration of drug activity | 4 hours | Metabolized mainly in liver |
| Bioavailability | Percentage of drug absorbed | 40-50% | Affected by gastric pH |
| Metabolism | Enzymes involved | CYP3A4 | Liver metabolism mainly |
| Excretion | How drug is eliminated | Feces and urine | Mainly fecal excretion |
dysfunction clinic; each had a lack of
Are there other uses for this medicine?
This study showed that doses of sildenafil between 50mg-100mg, with the mean study dose of 91.7 mg, lead to an improvements in sexual side effects in the treatment group compared to the placebo control group. 28% of women taking sildenafil reported no improvement with the treatment, while 73% of women taking placebo reported no improvement. There was no statistical difference in the baseline and end-of-study Hamilton depression scores. While there were no baseline endocrine value differences between the two groups, participants with higher levels of testosterone and thyroxin were more likely to experience improvement in sexual function, regardless of the assigned treatment group. Headache, flushing, dyspepsia, nasal congestion, and transient visual disturbances were the most common adverse events reported with sildenafil use in this study; nausea and increased anxiety were more commonly reported in the placebo group than the study group.
Drug information
This is the first randomized placebo-controlled study to show a significant decrease in sexual side effects when looking at the use of sildenafil in premenopausal women with SSRI-associated sexual dysfunction, supporting previous case reports and open label studies of this medication in this population. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil Treatment of Women with Antidepressant-Associated Sexual Dysfunction. DARE to PLAY is a topical sildenafil cream enhancing female arousal, available in select states as a compounded product while awaiting FDA approval. Clinical trials showed improved arousal sensation scores, though not statistically significant compared to placebo, with significant benefits in a subset of women with FSAD.
Knowledge Gaps in Urologic Care of Female Spinal Cord Injury Patients
Daré Bioscience said the sildenafil cream’s availability will expand to other states throughout December 2025 and early 2026. DARE to PLAY, a proprietary topical arousal cream designed to enhance genital blood flow and arousal response in women, can now be prescribed in select states, manufacturer Daré Bioscience, Inc announced in a news release.1 “When Viagra [sildenafil citrate] was approved in 1998, it revolutionized sexual medicine for men. But for women, comparable progress on enhancing the natural arousal sensations has stalled for nearly 3 canadian sildenafil citrate decades,” said Sabrina Martucci Johnson, President and CEO of Daré Bioscience, in the news release. “We believe DARE to PLAY represents a long overdue correction, giving women an option to reconnect with their own bodies, their pleasure, and their confidence, using science that finally recognizes their needs.”1 As the company continues the process to seek FDA approval of the sildenafil cream formulation, it is making the cream available in the form of a Section 503B compounded product. Although the sildenafil cream is manufactured “in an outsourcing facility subject to FDA inspection and under current Good Manufacturing Practice regulations,” Daré Bioscience noted that compounded drugs are not FDA approved or evaluated by the agency for “safety, effectiveness, or quality.”1 DARE to PLAY is currently available for prescription for pre-order in Connecticut, Florida, Indiana, Missouri, New Jersey, Oregon, Pennsylvania, Rhode Island, and Utah. vaginal lubrication and a lack of clitoral
How does it work?
Daré Bioscience said the sildenafil cream’s availability will expand to other states throughout December 2025 and early 2026.1 DARE to PLAY has been evaluated in several studies, including a phase 2b randomized controlled trial (NCT04948151), the results of which were published in Obstetrics & Gynecology. In that study, 200 women with female sexual arousal disorder (FSAD) were randomly assigned to receive the sildenafil cream or placebo cream. The co-primary efficacy end points included change from baseline to week 12 in the Arousal Sensation domain of the Sexual Function Questionnaire (SFQ28), as well as question 14 of the Female Sexual Distress Scale—Desire, Arousal, Orgasm (FSDS-DAO).2 Greater improvement in SFQ28 Arousal Sensation domain scores was observed in patients receiving sildenafil cream, although “there were no statistically significant differences between sildenafil and placebo cream users in the coprimary and secondary efficacy end points,” wrote the authors. The investigators also conducted an exploratory post hoc analysis evaluating a subset of the intention-to-treat population who had a diagnosis of FSDD with or without concomitant decreased desire. In this subset, significant increases in SFQ28 Arousal Sensation domain score were seen vs the placebo group. and vaginal sensation or slow sexual response.
- Female patients should be cautious with sildenafil due to lack of approval.
- Erectile dysfunction medications can interact with other drugs, affecting women as well.
- Some studies suggest sildenafil may help women with arousal issues but are inconclusive.
- Sildenafil may improve clitoral blood flow, enhancing sensitivity.
- Libido enhancement from sildenafil varies based on individual health factors.
- Self-medicating women with sildenafil without supervision can be risky.